Lv1
68 积分 2024-11-14 加入
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
6天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
12天前
已完结
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
12天前
已完结
Progress in immunotherapy for resectable head and neck squamous cell carcinoma
20天前
已完结
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
20天前
已完结
Validation of the Generic Version of China Health Related Outcomes Measures (CHROME‐G) among individuals with type 2 diabetes in China
20天前
已完结
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
21天前
已完结
Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts
21天前
已关闭
Endometrial cancer
21天前
已关闭
Endometrial cancer
21天前
已完结
皖公网安备34019202002308
